Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global PVA Embolization Particles Market Segment Research Report 2022, which aims to sort out the development status and trends of the PVA Embolization Particles industry at home and abroad, estimate the overall market scale of the PVA Embolization Particles industry and the market share of major countries, analyze the development potential of each segment of the PVA Embolization Particles industry, and study and judge the downstream market demand of PVA Embolization Particles through systematic research, Analyze the competition pattern of PVA Embolization Particles, so as to help solve the pain points of various stakeholders in PVA Embolization Particles industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of PVA Embolization Particles Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in PVA Embolization Particles Market
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Major Type of PVA Embolization Particles Covered in XYZResearch report:
Conventional/Irregular PVA
Compressible and Spherical PVA
Application Segments Covered in XYZResearch Market
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global PVA Embolization Particles Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global PVA Embolization Particles Market by Value
2.2.1 Global PVA Embolization Particles Revenue by Type
2.2.2 Global PVA Embolization Particles Market by Value (%)
2.3 Global PVA Embolization Particles Market by Production
2.3.1 Global PVA Embolization Particles Production by Type
2.3.2 Global PVA Embolization Particles Market by Production (%)
3. The Major Driver of PVA Embolization Particles Industry
3.1 Historical & Forecast Global PVA Embolization Particles Demand
3.2 Largest Application for PVA Embolization Particles (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional PVA Embolization Particles Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of PVA Embolization Particles Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US PVA Embolization Particles Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe PVA Embolization Particles Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China PVA Embolization Particles Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan PVA Embolization Particles Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India PVA Embolization Particles Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea PVA Embolization Particles Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia PVA Embolization Particles Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global PVA Embolization Particles Average Price Trend
12.1 Market Price for Each Type of PVA Embolization Particles in US (2018-2022)
12.2 Market Price for Each Type of PVA Embolization Particles in Europe (2018-2022)
12.3 Market Price for Each Type of PVA Embolization Particles in China (2018-2022)
12.4 Market Price for Each Type of PVA Embolization Particles in Japan (2018-2022)
12.5 Market Price for Each Type of PVA Embolization Particles in India (2018-2022)
12.6 Market Price for Each Type of PVA Embolization Particles in Korea (2018-2022)
12.7 Market Price for Each Type of PVA Embolization Particles in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 PVA Embolization Particles Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of PVA Embolization Particles
14. PVA Embolization Particles Competitive Landscape
14.1 Sirtex Medical
14.1.1 Sirtex Medical Company Profiles
14.1.2 Sirtex Medical Product Introduction
14.1.3 Sirtex Medical PVA Embolization Particles Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merit Medical
14.2.1 Merit Medical Company Profiles
14.2.2 Merit Medical Product Introduction
14.2.3 Merit Medical PVA Embolization Particles Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Cook Medical
14.3.1 Cook Medical Company Profiles
14.3.2 Cook Medical Product Introduction
14.3.3 Cook Medical PVA Embolization Particles Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 BTG Medical
14.4.1 BTG Medical Company Profiles
14.4.2 BTG Medical Product Introduction
14.4.3 BTG Medical PVA Embolization Particles Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Boston Scientific Corporation
14.5.1 Boston Scientific Corporation Company Profiles
14.5.2 Boston Scientific Corporation Product Introduction
14.5.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Terumo Corporation
14.6.1 Terumo Corporation Company Profiles
14.6.2 Terumo Corporation Product Introduction
14.6.3 Terumo Corporation PVA Embolization Particles Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 HENGRUI Medical
14.7.1 HENGRUI Medical Company Profiles
14.7.2 HENGRUI Medical Product Introduction
14.7.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 INterface BIOmaterials
14.8.1 INterface BIOmaterials Company Profiles
14.8.2 INterface BIOmaterials Product Introduction
14.8.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Alicon
14.9.1 Alicon Company Profiles
14.9.2 Alicon Product Introduction
14.9.3 Alicon PVA Embolization Particles Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
15. Conclusion